Ada Gawrychowska

Dr. Ada Gawrychowska

Department of Paediatrics, Haematology and Oncology, Clinical University Centre, 7 Debinki Street, 80-952 Gdansk, Poland
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 January 2022 in Diagnostics
Verified
Journal Article
Open access
PDF file
MJMichalina Jezierska
Michalina Jezierska
AGAda Gawrychowska
Ada Gawrychowska
JSJoanna Stefanowicz
Joanna Stefanowicz
Germ cell tumors (GCTs) are a heterogenous group of neoplasms in children and young adults, in which serum tumor markers have been demonstrated to be highly sensitive diagnostic and monitoring tools. The known "old" serum biomarkers, alpha-fetoprotein (AFP), human choriogonadotropin (β-hCG) and lactate dehydrogenase (LDH), have some limitations in sensitivity and specificity. MIRNAs from the miR-371~373 (chromosomal locus 19q13.41) and miR-302/367 (4q25) clusters are universally over-expressed in malignant GCT tissue samples. The levels of miRNAs from these clusters are elevated in the serum. They seem to be highly sensitive and specific in malignant GCTs diagnosis and disease assessment during treatment and follow-up. The aim of our review was to present the role of serum tumor markers in the clinical staging, treatment monitoring and follow-up of pediatric patients with GCTs and show new possibilities. The serum levels of miRNAs seem to be a new, promising essential tool in the clinical management of GCTs.

10 December 2020 in Diagnostics
Verified
Journal Article
Open access
PDF file
AGAda Gawrychowska
Ada Gawrychowska
EIEwa Izycka-Swieszewska
Ewa Izycka-Swieszewska
BLBeata S. Lipska-Ziętkiewicz
Beata S. Lipska-Ziętkiewicz
DKDominika Kuleszo
Dominika Kuleszo
JBJoanna Bautembach-Minkowska
Joanna Bautembach-Minkowska
JSJoanna Stefanowicz
Joanna Stefanowicz
This article reports a case of a 7-year-old girl with Turner syndrome, treated with growth hormone (GH), who developed ovarian dysgerminoma. The patient karyotype was mosaic for chromosome Xq deletion: 46,X,del(X)(q22)/45,X. No Y chromosome sequences were present. Molecular studies revealed the presence of a driving mutation in exon 17 of the KIT gene in the neoplastic tissue, as well as Sonic-hedgehog (SHH) pathway activation at the protein level. The patient responded well to chemotherapy and remained in complete remission. This is the first case of dysgerminoma in a Turner syndrome patient with such oncogenic pathway.

14 June 2026 in Pediatria Polska
Verified
Journal Article
Open access
PDF file
AGAda Gawrychowska
Ada Gawrychowska
MMMaciej Murawski
Maciej Murawski
KSKatarzyna Sinacka
Katarzyna Sinacka
ACAleksandra Ciarka
Aleksandra Ciarka
AJAnna Jankowska
Anna Jankowska
JSJoanna Stefanowicz
Joanna Stefanowicz
Due to their rarity and often large size at diagnosis, abdominal teratomas in newborns are often challenging to diagnose and treat. We would like to present the case of a newborn with a massive abdominal mass, initially misdiagnosed as a microcystic mesenteric lymphatic malformation, which revealed to be immature teratoma. This case report highlights the challenges associated with the differential diagnosis and surgical management of neonatal abdominal teratomas. It contributes to the literature by presenting diagnostic dilemmas that ultimately led to the accurate identification of this condition.